Literature DB >> 2468410

Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors.

P E Mansson1, P Adams, M Kan, W L McKeehan.   

Abstract

Heparin-binding polypeptide growth factors (HBGF) are essential mitogens for isolated prostate cells. HBGF type one (HBGF-1) mRNA was expressed specifically in the epithelial cells of prostates from normal 6- to 8-week-old rats. Expression declined significantly at 14 weeks and was undetectable in 35-week-old animals. Slow-growing, androgen-responsive, nonmetastatic Dunning R3327PAP tumors, which are composed of a well-defined epithelium and stroma, expressed HBGF-1 mRNA constitutively in specifically the mesenchymal cells. A rapid-growing, androgen-independent, metastatic variant (Dunning R3327AT-3), which was composed of a single clonogenic cell type, expressed both HBGF-1 and HBGF type two (HBGF-2) mRNA. HBGF activity in the extracts of normal and tumor tissues correlated with mRNA levels. Epithelial cells from the R3327PAP tumor and the single cell type that composed the R3327AT-3 tumor exhibited alterations in HBGF receptor characteristics that correlated with increased sensitivity to mitogenic effects of HBGF. The results suggest that alterations in HBGF gene expression in both prostate epithelial and mesenchymal cells and in properties of the receptor in specifically epithelial cells may contribute to differential growth rates and malignancy of different prostatic tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468410

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Heparin-binding growth factors and their receptors.

Authors:  B B Olwin
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  Heparin-binding (fibroblast) growth factors type one and two genes are co-expressed in proliferating normal human vascular endothelial and smooth muscle cells in culture.

Authors:  P E Mansson; M Malark; H Sawada; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol       Date:  1990-02

3.  Sequence of rat keratinocyte growth factor (heparin-binding growth factor type 7)

Authors:  G C Yan; S Nikolaropoulos; F Wang; W L McKeehan
Journal:  In Vitro Cell Dev Biol       Date:  1991-06

4.  Endothelial cells support the growth of prostate tissue in vivo.

Authors:  Michael Bates; Bruce Kovalenko; E Lynette Wilson; David Moscatelli
Journal:  Prostate       Date:  2008-06-01       Impact factor: 4.104

5.  Insulin-like growth factor-1 messenger RNA isoforms in rat prostate and prostate tumors.

Authors:  F Wang; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-05       Impact factor: 2.416

Review 6.  Bone metastasis: mechanisms and therapeutic opportunities.

Authors:  Larry J Suva; Charity Washam; Richard W Nicholas; Robert J Griffin
Journal:  Nat Rev Endocrinol       Date:  2011-01-04       Impact factor: 43.330

7.  Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy.

Authors:  G Yan; Y Fukabori; G McBride; S Nikolaropolous; W L McKeehan
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

8.  Identification of a fibroblast growth factor-binding protein in Drosophila melanogaster.

Authors:  J S Doctor; F M Hoffmann; B B Olwin
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

9.  Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants.

Authors:  E Shi; M Kan; J Xu; F Wang; J Hou; W L McKeehan
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

10.  Receptor phenotype underlies differential response of hepatocytes and nonparenchymal cells to heparin-binding fibroblast growth factor type 1 (aFGF) and type 2 (bFGF).

Authors:  M Kan; G C Yan; J Xu; M Nakahara; J Hou
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.